Presenting the world's strongest battery in Davos: News tip to the media from Chalmers University of Technology
Meeting Announcement
Updates every hour. Last Updated: 31-May-2026 16:15 ET (31-May-2026 20:15 GMT/UTC)
During the World Economic Forum (WEF) in Davos on 19–23 January 2026, Chalmers University of Technology, Sweden participates in Science House – an international meeting place for science, innovation and sustainable societal development. We invite journalists to find out about the latest advanced of the world’s strongest battery, and to interview the researcher who thinks that technologies such as AI isn’t “stealing” human jobs – but something we need to address Europe’s imminent skill shortage.
Researchers have created a self-healing composite that is tougher than materials currently used in aircraft wings, turbine blades and other applications – and can repair itself more than 1,000 times. The researchers estimate their self-healing strategy can extend the lifetime of conventional fiber-reinforced composite materials by centuries compared to the current decades-long design-life.
Chemical looping fluidized bed reactors are an innovative technology for green hydrogen and chemical production. Recently, researchers have comprehensively reviewed the latest developments in chemical looping, with a focus on fluidized bed design and oxygen carrier performance. The findings of the study can pave the way for low-emission power generation, inherent carbon dioxide separation, carbon footprint reduction, and industrial decarbonization.
Coffee beans that pass through the digestive tracts of animals get their unique flavors from the activity of gut microbes, report researchers from the Institute of Science Tokyo. The guts of Asian elephants that produce Black Ivory coffee (BIC) were rich in pectin-digesting bacteria. Heat-driven degradation of pectin during roasting makes coffee bitter. Bacterial activity that reduces the pectin content of BIC could be the source of its smoother, chocolaty, and less bitter flavor.
CRISPR–Cas9-based therapies are widely investigated for their clinical applications. However, there are limitations associated with the strategy, including off-target DNA editing. A group of researchers from Japan has explored a novel strategy involving CRISPR–Cas3 and investigated its potential using a mouse model of transthyretin amyloidosis (ATTR). The results highlight its potential as an efficient genome-editing system. The technology can be developed as a therapeutic strategy for treating ATTR and other genetic disorders.
Infertility is a major healthcare concern. Understanding the molecular regulators governing fertilization, early embryonic development, and implantation is crucial for the success of assisted reproductive technologies. Now, researchers from Kanazawa Medical University integrated one-cell embryo cryopreservation technology, inhibitor library screening, RNA-seq analysis, and CRISPR-Cas9-mediated gene editing to identify eleven novel factors essential for the development of fertilized eggs. The study contributes towards a better understanding of the underlying mechanisms.